US Patent

US10464918 — Process of making somatostatin modulators

Composition of Matter · Assigned to Crinetics Pharmaceuticals Inc · Expires 2039-01-16 · 13y remaining

Vulnerability score 17/100 Ironclad — strong claim type, well-established, deep family

What this patent protects

This patent protects a process for making somatostatin modulators, which are compounds that can be used to treat various conditions.

USPTO Abstract

Described herein are compounds that are somatostatin modulators, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders that would benefit from modulation of somatostatin activity.

Drugs covered by this patent

Patent Metadata

Patent number
US10464918
Jurisdiction
US
Classification
Composition of Matter
Expires
2039-01-16
Drug substance claim
Yes
Drug product claim
No
Assignee
Crinetics Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.